Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis.
Structure of the first sphingosine 1-phosphate receptor.
Self-management for people with long-term neurological conditions.
Cognitive Impairment Has a Strong Relation to Nonsomatic Symptoms of Depression in Relapsing-Remitting Multiple Sclerosis.
Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
Effects of sleep and wake on oligodendrocytes and their precursors.
Central nervous system lymphoma associated with natalizumab.
Video game training enhances cognitive control in older adults.
Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.
Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.
The genetic and environmental bases of complex human-disease: extending the utility of twin-studies.
B cells and antibodies in multiple sclerosis pathogenesis and therapy.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
Tremor reduction and quality of life after deep brain stimulation for multiple sclerosis-associated tremor.
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
Multiple sclerosis and stress.
Innovation at RUSH
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ(42))-Induced Impairment of Spatial Learning and Memory in Rats.
A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.

Pages